Medicus

About Medicus

Medicus AI is a technology company that provides an AI-based platform to interpret and translate health data and medical reports into personalized, visual, and easily understandable insights. Founded in 2015 by Dr. Baher Al Hakim, Nadine Nehme, and Makram Saleh, the company was first established in Dubai and later incorporated in Vienna, Austria in 2016 to facilitate European expansion. Dr. Baher Al Hakim, a dentist by study and a serial entrepreneur, serves as the CEO, leveraging his background in technology and business to address the complexity of healthcare information. Co-founder Nadine Nehme, the Chief Science Officer, brings her expertise in medical research, genetics, and genomics to the company.

The company operates on a B2B2C business model, licensing its white-labeled, integrated platforms to healthcare providers such as diagnostic labs, hospitals, and insurance companies. These clients then offer the service to their end-users—patients and doctors. The platform's core product, 'Smart Reports', processes diagnostic lab results and other health data, converting them into interactive reports with actionable recommendations and lifestyle coaching. This empowers patients to better understand and manage their health while providing doctors with tools for smart testing and diagnosis support. Medicus AI also offers 'HomeWell', a home testing medical service, and 'Smart Wellbeing', a platform for health coaching. The business generates revenue by enabling its clients to offer value-added services, thereby improving patient retention and modernizing their offerings.

Medicus serves markets across Europe and the Middle East, with a combined patient reach of over 35 million. The platform supports multiple languages including English, German, French, and Arabic. The company has engaged in several funding rounds, including a Series A round in 2019, to fuel its global expansion and product development. It has also formed strategic partnerships, notably a market access cooperation with Roche Diagnostics, to enhance its global reach.